Premium
P4‐269: A pharmacogenetic‐supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease (AD)
Author(s) -
Roses Allen D.,
WelshBohmer Kathleen,
Burns Daniel,
Chiang Carl,
Crenshaw Donna G.,
Lutz Michael W.,
Metz Craig,
Saunders Ann M.,
Talbott Sheila,
Yarbrough Deborah,
Brannan Stephen
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.08.050
Subject(s) - biomarker , pioglitazone , placebo , medicine , disease , cognitive decline , clinical trial , oncology , dementia , pathology , endocrinology , diabetes mellitus , type 2 diabetes , genetics , biology , alternative medicine